This study first showed that low levels of adropin significantly increased the predictive ability of NT-proBNP for asymptomatic HFpEF in patients with T2DM, even when the NT-proBNP levels were low, while adropin added discriminatory power at all NT-proBNP levels. Here, NPPB is linked to type 2 diabetes mellitus.